logo
logo
Ardent Health Partners, Inc.

Ardent Health Partners, Inc.

NYSE•ARDT
CEO: Mr. Martin J. Bonick FACHE, M.H.A.
セクター: Healthcare
業種: Medical - Care Facilities
上場日:
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
連絡先情報
340 Seven Springs Way, Suite 100, Brentwood, TN, 37027, United States
615-296-3000
www.ardenthealth.com
時価総額
$1.40B
PER (TTM)
6.7
17
配当利回り
--
52週高値
$15.59
52週安値
$8.07
52週レンジ
23%
順位41Top 44.9%
4.0
F-Score
改良版 Piotroski 分析
8年ファンダメンタル
堅調 • 4 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2018-2025

財務ダッシュボード

Q3 2025 データ

売上高

$1.58B+8.76%
直近4四半期の推移

EPS

-$0.17-189.47%
直近4四半期の推移

フリーCF

$93.00M+91.02%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Revenue Growth Strong Total revenue grew 8.8% to $1.58 B for the quarter; 9-month revenue increased 8.2% to $4.72 B.
Operating Cash Flow Improves Nine-month cash provided by operations reached $247.075 M, up $51.618 M from prior period, supporting liquidity.
Liquidity Position Solid Cash and equivalents totaled $609.441 M at period end; available liquidity stood at $903.8 M for needs.
Debt Refinancing Completed Term Loan B refinanced in September 2025, reducing applicable interest rate by 50 basis points immediately.

リスク要因

Quarterly Net Loss Reported Net loss attributable to Ardent Health, Inc. was $(23.478) M for the quarter, reversing prior period income.
Professional Liability Reserves Surge $47.2 M professional liability reserve increase, driven by New Mexico adverse claim developments, impacted Q3 results.
Regulatory Environment Uncertainty OBBBA legislation introduces uncertainty regarding Medicaid funding mechanisms and potential federal payment reductions.
Labor Costs Remain High Competition and minimum wage increases in some markets create ongoing pressure on salaries and benefits expenses.

見通し

Continue Acquisition Strategy Completed acquisition of 18 urgent care clinics in January 2025 for $27.5 M, planning further growth.
Manage Revenue Estimate Change Implemented new revenue accounting system, resulting in $42.6 M revenue decrease due to improved collectability estimates.
Capital Expenditures Planned Expect to finance future capital expenditures with internally generated funds and borrowed funds for modernization.
Debt Covenants Compliance Management believes compliance maintained with all financial covenants under the Ventas Master Lease as of September 30, 2025.

同業比較

売上高 (TTM)

Ardent Health Partners, Inc.ARDT
$6.33B
+10.9%
Select Medical Holdings CorporationSEM
$3.93B
-35.0%
Acadia Healthcare Company, Inc.ACHC
$3.27B
+4.6%

粗利益率 (最新四半期)

Acadia Healthcare Company, Inc.ACHC
96.4%
+0.1pp
ImmunityBio, Inc.IBRX
87.1%
-12.9pp
Ardent Health Partners, Inc.ARDT
57.1%
-25.6pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
IBRX$5.93B-16.362.8%0.0%
BKD$3.96B-14.8-229.8%0.0%
LFST$2.74B-298.8-0.6%22.0%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-0.6%
横ばい
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい

深度リサーチ

次回決算:2026年2月25日
|
EPS:$0.35
|
売上高:-
財務レポート
財務データ
ニュース
全年度

  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月14日|
    売上高: $1.58B+8.8%
    |
    EPS: $-0.17-189.5%
    予想を下回る

  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年8月6日|
    売上高: $1.65B+11.9%
    |
    EPS: $0.52+73.3%
    予想を上回る

  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月7日|
    売上高: $1.50B+4.0%
    |
    EPS: $0.30+57.9%
    予想を上回る

  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年2月27日|
    売上高: $5.97B+10.3%
    |
    EPS: $1.59+354.3%
    予想を上回る

  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月7日|
    売上高: $1.45B+5.2%
    |
    EPS: $0.19+26.7%
    予想を下回る

  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月14日|
    売上高: $1.47B+7.5%
    |
    EPS: $0.30+30.4%
    予想通り